Over the past few years, there has been a growing body of evidence indicating that resveratrol targets STAT3, PI3K/Akt/mTOR, and MAPK/ERK proapoptotic and antiproliferative signaling, which could have the potential to be used as a treatment for BC [127, 128]. Here, AKT1 is linked to breast cancer.